drugset / Trial / NCT00050388
Phase II Trial of Allovectin-7® for Head and Neck Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this clinical trial is to determine if Allovectin-7®, an experimental gene-based immunotherapy, can shrink head and neck tumors. The trial will also examine if treatment can boost the immune system and if this treatment can improve the time to disease progression.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- 2002-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allovectin-7® | Other / unclassified | — | Other |